Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Zolk

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Canadian Journal of Physiology and Pharmacology|March 18, 2000
Heterotrimeric G proteins in heart diseaseO Zolk, I Kouchi, P Schnabel, et al.
International Journal of Oral and Maxillofacial Surgery|October 2, 2019
Antibiotic prophylaxis of infective endocarditis in oral and maxillofacial surgery: incomplete implementation of guidelines in everyday clinical practiceS Hafner, M Albittar, E Abdel-Kahaar, et al.
Cardiovascular Research|October 9, 1998
Alteration of intracellular Ca2(+)-handling and receptor regulation in hypertensive cardiac hypertrophy: insights from Ren2-transgenic ratsO Zolk, M Flesch, G Nickenig, et al.
Hypertension (Dallas, Tex. : 1979)|May 12, 1998
Vascular beta-adrenergic receptor adenylyl cyclase system from renin-transgenic hypertensive ratsG Sitzler, O Zolk, U Laufs, et al.
British Journal of Pharmacology|October 2, 2010
Double-transfected MDCK cells expressing human OCT1/MATE1 or OCT2/MATE1: determinants of uptake and transcellular translocation of organic cationsJ König, O Zolk, K Singer, et al.
Journal of Molecular and Cellular Cardiology|February 1, 1997
The role of Gi-proteins and beta-adrenoceptors in the age-related decline of contraction in guinea-pig ventricular myocytesN Ferrara, M Böhm, O Zolk, et al.
European Journal of Pharmacology|May 4, 1999
Beneficial effects of amiodarone in heart failure: interaction with beta-adrenoceptors rather than G proteinsP Schnabel, F Mies, C Maack, et al.
Hypertension (Dallas, Tex. : 1979)|June 11, 1998
Salt induces vascular AT1 receptor overexpression in vitro and in vivoG Nickenig, K Strehlow, J Roeling, et al.
Annals of the Rheumatic Diseases|January 14, 2009
Lumiracoxib inhibits cyclo-oxygenase 2 completely at the 50 mg dose: is liver toxicity avoidable by adequate dosing?B Hinz, B Renner, O Cheremina, et al.
Clinical Pharmacology and Therapeutics|September 6, 2012
Personalizing antiplatelet therapy with clopidogrelD Trenk, O Zolk, M F Fromm, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Canadian Journal of Physiology and Pharmacology|March 18, 2000
Heterotrimeric G proteins in heart diseaseO Zolk, I Kouchi, P Schnabel, et al.
International Journal of Oral and Maxillofacial Surgery|October 2, 2019
Antibiotic prophylaxis of infective endocarditis in oral and maxillofacial surgery: incomplete implementation of guidelines in everyday clinical practiceS Hafner, M Albittar, E Abdel-Kahaar, et al.
Cardiovascular Research|October 9, 1998
Alteration of intracellular Ca2(+)-handling and receptor regulation in hypertensive cardiac hypertrophy: insights from Ren2-transgenic ratsO Zolk, M Flesch, G Nickenig, et al.
Hypertension (Dallas, Tex. : 1979)|May 12, 1998
Vascular beta-adrenergic receptor adenylyl cyclase system from renin-transgenic hypertensive ratsG Sitzler, O Zolk, U Laufs, et al.
British Journal of Pharmacology|October 2, 2010
Double-transfected MDCK cells expressing human OCT1/MATE1 or OCT2/MATE1: determinants of uptake and transcellular translocation of organic cationsJ König, O Zolk, K Singer, et al.
Journal of Molecular and Cellular Cardiology|February 1, 1997
The role of Gi-proteins and beta-adrenoceptors in the age-related decline of contraction in guinea-pig ventricular myocytesN Ferrara, M Böhm, O Zolk, et al.
European Journal of Pharmacology|May 4, 1999
Beneficial effects of amiodarone in heart failure: interaction with beta-adrenoceptors rather than G proteinsP Schnabel, F Mies, C Maack, et al.
Hypertension (Dallas, Tex. : 1979)|June 11, 1998
Salt induces vascular AT1 receptor overexpression in vitro and in vivoG Nickenig, K Strehlow, J Roeling, et al.
Annals of the Rheumatic Diseases|January 14, 2009
Lumiracoxib inhibits cyclo-oxygenase 2 completely at the 50 mg dose: is liver toxicity avoidable by adequate dosing?B Hinz, B Renner, O Cheremina, et al.
Clinical Pharmacology and Therapeutics|September 6, 2012
Personalizing antiplatelet therapy with clopidogrelD Trenk, O Zolk, M F Fromm, et al.
Pageof 4